Eli Lilly, AbbVie Exit Drug Pricing Agreement in UK
According to an industry body, pharmaceutical companies AbbVie and Eli Lilly had withdrawn from Britain’s voluntary medicines pricing agreement. According to a statement released by the Association of the British Pharmaceutical Industry (ABPI), businesses are increasingly arguing that it is no longer possible to justify the UK’s “voluntary scheme” to global boardrooms and investors as […]
Continue Reading